SM Biomed specializes in the development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs) and Intermediates for both domestics and international markets. Founded in 1991, the company operates a manufacturing facility that complies with both national and international regulatory standards. SM Biomed is a leader in the pharmaceutical API sector and holds a pioneering position in Malaysia’s pharmaceutical API industry. SM Biomed takes pride in delivering high-quality products at competitive prices, complemented by excellent customer service. Over 30 years of experience in API development and manufacturing – we have successfully expanded our reach to more than 60 countries across five continents, from Asia to the US.SM Biomed has a subsidiary, SM Pharmaceuticals, which is one of the largest exporters of pharmaceutical formulation products from Malaysia to the rest of the world.